Insider digest · LLY
Eli Lilly insider filings, Nov 17, 2026
Eli Lilly insiders filed 11 routine Form 4 reports on Nov 17, 2026: awards. None of them was a purchase or a sale in the market. This page groups them in one place; each row links to the filing note, and each number links to the Form 4 itself.
What the codes mean: how to read a Form 4 · stock-based compensation.
Stock awards and grants
Shares or units the company granted as pay. No shares were bought or sold in the market. Total for the day: 1,884 shares or units, worth about $2,697,674 at the prices reported.
The filings
- Eli Lilly director Ralph Alvarez reports an award of about 176 shares · SEC filing index
- Eli Lilly director J. Erik Fyrwald reports an award of about 175 shares · SEC filing index
- Eli Lilly director Juan R. Luciano reports an award of about 179 shares · SEC filing index
- Eli Lilly director Gabrielle Sulzberger reports an award of about 171 shares · SEC filing index
- Eli Lilly director Mary Lynne Hedley reports an award of about 168 shares · SEC filing index
- Eli Lilly director Katherine Baicker reports an award of about 168 shares · SEC filing index
- Eli Lilly director Carolyn R. Bertozzi reports an award of about 178 shares · SEC filing index
- Eli Lilly director Kimberly H. Johnson reports an award of about 168 shares · SEC filing index
- Eli Lilly director William G. Kaelin, Jr. reports an award of about 168 shares · SEC filing index
- Eli Lilly director Jon R. Moeller reports an award of about 168 shares · SEC filing index
- Eli Lilly director Jamere Jackson reports an award of about 168 shares · SEC filing index
Eli Lilly company file → · All Eli Lilly filings notes
Disclosures
- Editor holdings in LLY
- The editor holds no position in Eli Lilly (LLY). As of Nov 11, 2026.
- Compensation
- Nobody paid for this page. No affiliate links.
A summary of public filings for general education, the same for every reader. Not a recommendation to buy, sell or hold LLY.